Transcriptomic biomarkers for tuberculosis: evaluation of DOCK9. EPHA4, and NPC2 mRNA expression in peripheral blood LS de Araujo, LAI Vaas, M Ribeiro-Alves, R Geffers, FCQ Mello, ... Frontiers in microbiology 7, 1586, 2016 | 52 | 2016 |
Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia H Arshad, JCL Alfonso, R Franke, K Michaelis, L Araujo, A Habib, ... Journal of translational medicine 17 (1), 1-18, 2019 | 40 | 2019 |
Reprogramming of small noncoding RNA populations in peripheral blood reveals host biomarkers for latent and active Mycobacterium tuberculosis infection LS de Araujo, M Ribeiro-Alves, T Leal-Calvo, J Leung, V Durán, M Samir, ... MBio 10 (6), 10.1128/mbio. 01037-19, 2019 | 28 | 2019 |
Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis LS de Araujo, NBM da Silva, RJ da Silva, JAM Leung, FCQ Mello, ... Tuberculosis 95 (6), 751-757, 2015 | 25 | 2015 |
Evaluation of gamma interferon immune response elicited by the newly constructed PstS-1 (285-374): CFP10 fusion protein to detect Mycobacterium tuberculosis infection LS Araujo, FCQ Mello, NBM da Silva, JAM Leung, SMA Machado, ... Clinical and Vaccine Immunology 21 (4), 552-560, 2014 | 23 | 2014 |
Assessment of the IgA Immunoassay Diagnostic Potential of the Mycobacterium tuberculosis MT10.3-MPT64 Fusion Protein in Tuberculous Pleural Fluid LS Araujo, RM Moraes, A Trajman, MHF Saad Clinical and vaccine immunology 17 (12), 1963-1969, 2010 | 23 | 2010 |
IgG subclasses' response to a set of mycobacterial antigens in different stages of Mycobacterium tuberculosis infection LS de Araujo, NBM da Silva, JAM Leung, FCQ Mello, MHF Saad Tuberculosis 108, 70-76, 2018 | 18 | 2018 |
Phosphatidylcholine PC ae C44: 6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis LS de Araujo, K Pessler, KW Sühs, N Novoselova, F Klawonn, M Kuhn, ... Journal of Translational Medicine 18, 1-8, 2020 | 13 | 2020 |
Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not … I Barilar, T Fernando, C Utpatel, C Abujate, CM Madeira, B José, ... The Lancet Infectious Diseases, 2023 | 6 | 2023 |
Close contact interferon-gamma response to the new PstS1(285–374):CPF10: a preliminary 1-year follow-up study LS de Araujo, N de Bárbara Moreira da Silva Lins, JAM Leung, FCQ Mello, ... BMC Research Notes 10, 1-9, 2017 | 6 | 2017 |
Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response LS de Araujo, M Ribeiro-Alves, MF Wipperman, CK Vorkas, F Pessler, ... Cells 10 (10), 2704, 2021 | 5 | 2021 |
Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial … L de Araujo, AM Cabibbe, L Mhuulu, A Diergaardt, V Dreyer, G Günther, ... Frontiers in Public Health 11, 1204064, 0 | 4 | |
Genomic epidemiology of SARS-CoV-2 during the first four waves in Mozambique N Ismael, S van Wyk, H Tegally, J Giandhari, JE San, M Moir, S Pillay, ... PLOS global public health 3 (3), e0001593, 2023 | 2 | 2023 |
Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana CR Baker, I Barilar, LS de Araujo, AW Rimoin, DM Parker, R Boyd, ... Emerging Infectious Diseases 29 (5), 977, 2023 | | 2023 |
High-resolution characterization of recent tuberculosis transmission in Botswana using geospatial and genomic data–the Kopanyo Study CR Baker, I Barilar, LS de Araujo, AW Rimoin, DM Parker, R Boyd, ... medRxiv, 2022.04. 13.22273731, 2022 | | 2022 |
Assessment of the IgA Immunoassay Diagnostic Potential of the Mycobacterium tuberculosis MT10. 3-MPT64 Fusion Protein in Tuberculous Pleural Fluid LS Araujo, R de Moraes Maciel, A Trajman, MHF Saad Clinical and vaccine immunology: CVI 18 (2), 352, 2011 | | 2011 |